Clinical and anamnesis risk factors for the development of ectopic pregnancy in women with infertility
Clinical review for general practice · 26.05.2026 · 7 (2) · 104-107
DOI: 10.47407/kr2026.7.2.00776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical review for general practice, online erschienen am 26.05.2026. Verfasst von Gulchekhra A Ikhtiyarova und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Ectopic pregnancy represents a serious medical and social problem that threatens both the reproductive function and life of a woman. In patients with infertility, the risk of its development is significantly higher, making the study of anamnesis factors and timely diagnosis particularly relevant.
Aim
To evaluate the clinical and anamnesis risk factors for the development of ectopic pregnancy in women with infertility and to optimize fertility restoration methods after tubal pregnancy based on minimally invasive organ-preserving surgical techniques. Materials and methods. A retrospective-prospective study was conducted in 2025 at the clinical base of the Department of Obstetrics and Gynecology, Bukhara Multidisciplinary Emergency Medical Center. The study included 200 reproductive-age women diagnosed with tubal pregnancy who underwent organ-preserving reconstructive surgery. Additionally, 80 clinical cases of ectopic pregnancy in women with infertility were analyzed, with prospective follow-up performed in 55 patients. The control group consisted of 35 somatically and gynecologically healthy reproductive-age women. Depending on the surgical method applied, patients with tubal pregnancy were divided into two comparable groups: Group 1 (n=100) – patients who underwent organ-preserving tubotomy without adjuvant therapy; Group 2 (n=100) – patients who underwent organ-preserving tubotomy with the use of Singclean gel as a barrier anti-adhesion agent.
Results
Three months after surgery, adhesion formation was detected in 25 (25.0%) women in Group 1, indicating postoperative complications and partial tubal obstruction. In Group 2, where Singclean gel was applied, tubal reocclusion was observed in only 9 (9.0%) patients and adhesions were absent in the majority of women, indicating a higher effectiveness in preventing postoperative adhesions. During one year of follow-up: in Group 2, intrauterine pregnancy occurred in 46 women, with a recurrence rate of ectopic pregnancy of only 2.0%; in Group 1, intrauterine pregnancy was recorded in 19 women, while recurrent ectopic pregnancy occurred in 43 patients.
Conclusion
The use of Singclean gel as a barrier anti-adhesion agent in organ-preserving tubotomy significantly improves surgical outcomes, reduces the risk of adhesion formation and recurrent ectopic pregnancy, making this approach preferable for fertility restoration in reproductive-age women. Keywords: ectopic pregnancy, rare forms of ectopic pregnancy, Singclean gel, infertility, early diagnosis, transvaginal ultrasonography, reproductive age.
Zitieren
APA
Ikhtiyarova, G. A., Dustova, N. K., Orazov, M. R., Ismatova, M. M., Khamroev, K. N., & Kayumova, G. M. (2026). Clinical and anamnesis risk factors for the development of ectopic pregnancy in women with infertility. Clinical review for general practice, 7(2), 104-107. https://doi.org/10.47407/kr2026.7.2.00776
Vancouver
Ikhtiyarova GA, Dustova NK, Orazov MR, Ismatova MM, Khamroev KN, Kayumova GM. Clinical and anamnesis risk factors for the development of ectopic pregnancy in women with infertility. Clinical review for general practice. 2026;7(2):104-107. doi:10.47407/kr2026.7.2.00776
BibTeX
@article{Ikhtiyarova2026,
author = {Ikhtiyarova, Gulchekhra A and Dustova, Nigora K and Orazov, Mekan R and Ismatova, Malika M and Khamroev, Khudoyshukur N and Kayumova, Guzal M},
title = {Clinical and anamnesis risk factors for the development of ectopic pregnancy in women with infertility},
journal = {Clinical review for general practice},
year = {2026},
volume = {7},
number = {2},
pages = {104--107},
doi = {10.47407/kr2026.7.2.00776}
}
EUVIMED